Your browser doesn't support javascript.
loading
Impact of the CYP2C19*17 Allele on Outcomes in Patients Receiving Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.
Lee, Craig R; Thomas, Cameron D; Beitelshees, Amber L; Tuteja, Sony; Empey, Philip E; Lee, James C; Limdi, Nita A; Duarte, Julio D; Skaar, Todd C; Chen, Yiqing; Cook, Kelsey J; Coons, James C; Dillon, Chrisly; Franchi, Francesco; Giri, Jay; Gong, Yan; Kreutz, Rolf P; McDonough, Caitrin W; Stevenson, James M; Weck, Karen E; Angiolillo, Dominick J; Johnson, Julie A; Stouffer, George A; Cavallari, Larisa H.
Afiliação
  • Lee CR; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Thomas CD; Department of Pharmacotherapy and Translational Research, Center for Pharmacogenomics and Precision Medicine, University of Florida, Gainesville, Florida, USA.
  • Beitelshees AL; University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Tuteja S; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Empey PE; School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Lee JC; Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, Illinois, USA.
  • Limdi NA; University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Duarte JD; Department of Pharmacotherapy and Translational Research, Center for Pharmacogenomics and Precision Medicine, University of Florida, Gainesville, Florida, USA.
  • Skaar TC; Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Chen Y; Department of Pharmacotherapy and Translational Research, Center for Pharmacogenomics and Precision Medicine, University of Florida, Gainesville, Florida, USA.
  • Cook KJ; Department of Pharmacotherapy and Translational Research, Center for Pharmacogenomics and Precision Medicine, University of Florida, Gainesville, Florida, USA.
  • Coons JC; School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Dillon C; University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Franchi F; Department of Medicine, Division of Cardiology, University of Florida, Jacksonville, Florida, USA.
  • Giri J; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Gong Y; Department of Pharmacotherapy and Translational Research, Center for Pharmacogenomics and Precision Medicine, University of Florida, Gainesville, Florida, USA.
  • Kreutz RP; Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • McDonough CW; Department of Pharmacotherapy and Translational Research, Center for Pharmacogenomics and Precision Medicine, University of Florida, Gainesville, Florida, USA.
  • Stevenson JM; School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Weck KE; Division of Cardiology and McAllister Heart Institute, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Angiolillo DJ; Department of Medicine, Division of Cardiology, University of Florida, Jacksonville, Florida, USA.
  • Johnson JA; Department of Pharmacotherapy and Translational Research, Center for Pharmacogenomics and Precision Medicine, University of Florida, Gainesville, Florida, USA.
  • Stouffer GA; Division of Cardiology and McAllister Heart Institute, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Cavallari LH; Department of Pharmacotherapy and Translational Research, Center for Pharmacogenomics and Precision Medicine, University of Florida, Gainesville, Florida, USA.
Clin Pharmacol Ther ; 109(3): 705-715, 2021 03.
Article em En | MEDLINE | ID: mdl-32897581
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trombose / Doença da Artéria Coronariana / Inibidores da Agregação Plaquetária / Intervenção Coronária Percutânea / Citocromo P-450 CYP2C19 / Variantes Farmacogenômicos / Clopidogrel Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Clin Pharmacol Ther Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trombose / Doença da Artéria Coronariana / Inibidores da Agregação Plaquetária / Intervenção Coronária Percutânea / Citocromo P-450 CYP2C19 / Variantes Farmacogenômicos / Clopidogrel Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Clin Pharmacol Ther Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos